Cancer drug development and therapeutics

This subclass comprises research and experimental development in cancer drug development and therapeutics.
Parent Category
 
 
 
 

UBC Researchers conducting research in Cancer drug development and therapeutics

J

Jiang, Xiaoyan

Department of Medical Genetics, Faculty of Medicine

Faculty (G+PS eligible/member)

Cancer drug development and therapeutics

L

Lallous, Nada

Department of Urologic Sciences, Faculty of Medicine

Faculty (G+PS eligible/member)

Cancer drug development and therapeutics; Cancer progression and metastasis; Cancer molecular targets; Biochemistry; Biophysics; Cancer biology; Therapeutics; Protein research; Drug resistance; transcription factors

Lau, Joseph

Department of Radiology, Faculty of Medicine

Faculty (G+PS eligible/member)

Cancer drug development and therapeutics; Nuclear medicine; Cancer; Radiopharmaceuticals; Imaging; Radiotherapy

Lockwood, William

Department of Pathology & Laboratory Medicine, Faculty of Medicine

Faculty (G+PS eligible/member)

Cancer progression and metastasis; Cancer drug development and therapeutics; Mechanisms of carcinogenesis; Cancer; drug discovery; Genetics; genomics; Immune response; Lung cancer; Oncogene signaling; Proteomics; Mouse models

M

Minchinton, Andrew

Faculty of Medicine

Faculty (non-G+PS member)

S

Segat, Gabriela

Faculty of Medicine

Postdoctoral Fellow

Mechanisms of carcinogenesis; Cancer drug development and therapeutics; Basic pharmacology; Applied immunology (including antibody engineering, xenotransplantation and t-cell therapies); Hematology; oncology; Inflammation; Epigenetics

V

Velenosi, Thomas

Faculty of Pharmaceutical Sciences

Faculty (G+PS eligible/member)

Pharmacology and pharmaceutical sciences, n.e.c.; Cancer drug development and therapeutics; Cancer molecular targets; Metabolomics; Lipid biology (including lipidomics); Pharmacometabolomics; Pharmacology; Lipidomics; mass spectrometry; Cancer; Stable isotope tracing; Bioinformatics
 
 
 
 
 
French Name
Thérapeutique et mise au point de médicaments contre le cancer
French Description
Cette sous-classe comprend la recherche et le développement expérimental en thérapeutique et mise au point de médicaments contre le cancer.
 
 

Get key application advice, hear about the latest research opportunities and keep up with the latest news from UBC's graduate programs.

Subscribe to GradProspect